Atara Biotherapeutics Inc.
Atara Biotherapeutics develops T‑cell immunotherapies, with lead product Tab‑cel in Phase 3 for EBV‑driven post‑transplant disease; it also pursues CAR T for blood and solid tumors in partnership with MSLK, QIMR, and Bayer.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Professional Services
- Industry: Biotechnology Research
- Employees: 38
- HQ: Thousand Oaks
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.